Antibody-based drug delivery systems for cancer therapy: Mechanisms, challenges, and prospects

In recent years, antibody-based cancer therapy has emerged as one of the efficient therapeutic strategies, such as immune checkpoint inhibitors (ICIs), angiogenesis inhibitors, antibody-drug conjugates (ADCs), multi-specific antibodies, and chimeric antigen receptor T (CAR-T) cells, among others. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhoujiang, Kankala, Ranjith Kumar, Yang, Zhiyong, Li, Wei, Xie, Songzhi, Li, Hanmei, Chen, Ai-Zheng, Zou, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131265/
https://www.ncbi.nlm.nih.gov/pubmed/35664074
http://dx.doi.org/10.7150/thno.72594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131265/
https://www.ncbi.nlm.nih.gov/pubmed/35664074
http://dx.doi.org/10.7150/thno.72594

Ejemplares similares